. Author manuscript; available in PMC: 2011 Jan 1.

Published in final edited form as: Cancer Prev Res (Phila). 2010 Jan;3(1):25–34. doi: 10.1158/1940-6207.CAPR-09-0200

Table 2.

Percent change in BCCs per year in subjects treated with placebo or celecoxib

	No. subjects	Placebo (95% CI)	Celecoxib (95% CI)	P_difference
All subjects (BCC number)	60	37% (25-50)	26% (17-36)	0.18
≥15 BCCs at baseline	24	28% (16-43)	32% (18-48)	0.74
<15 BCCs at baseline	36	48% (27-71)	22% (10-36)	0.043
All subjects (BCC burden)	60	37% (24-50)	25% (15-36)	0.069
≥15 BCCs at baseline	24	33% (19-48)	33% (18-50)	0.97
<15 BCCs at baseline	36	50% (28-76)	20% (6.8-35)	0.024

Abbreviation: 95% CI, 95% confidence interval.